LEGN
Legend Biotech Corp
18.60$
-3.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 50.7% | 40.8% | 58.2% | 27.0% | 34.6% | 39.6% | 36.6% | 38.4% | 42.3% | 40.3% | 57.7% | 35.5% | 43.4% | |
| 49.3% | 59.2% | 41.8% | 73.0% | 65.4% | 60.4% | 63.4% | 61.6% | 57.7% | 59.7% | 42.3% | 64.5% | 56.6% | |
| 99.8% | 133.0% | 107.4% | 60.4% | 59.6% | 56.0% | 52.3% | 38.5% | 41.5% | 33.1% | 28.2% | 24.8% | 31.2% | |
| 29.3% | 36.1% | 34.0% | 19.0% | 22.0% | 18.3% | 16.1% | 12.8% | 12.7% | 12.1% | 13.1% | 8.5% | 11.4% | |
| 145.7% | 210.0% | 167.2% | 95.5% | 109.1% | 100.3% | 89.4% | 70.2% | 73.6% | 66.4% | 58.7% | 49.7% | 61.0% | |
| -96.4% | -150.8% | -125.4% | -22.5% | -43.7% | -39.9% | -26.0% | -8.6% | -16.0% | -6.7% | -16.3% | 14.9% | -4.4% | |
| 5.9% | 7.3% | 5.8% | 2.9% | 3.4% | 2.8% | 2.6% | 2.1% | 2.1% | 1.8% | 1.8% | 0.1% | 1.3% | |
| -65.1% | -184.8% | -63.6% | -9.6% | -75.5% | 21.7% | -50.8% | -48.9% | -14.3% | -6.4% | -17.4% | 14.3% | -4.4% | |
| -0.3% | -2.5% | 0.0% | 0.1% | 2.8% | 7.6% | 0.9% | 0.2% | 0.2% | 3.7% | 0.4% | 5.8% | 2.8% | |
| -64.8% | -182.2% | -63.6% | -9.8% | -78.2% | 14.1% | -51.7% | -49.2% | -14.6% | -10.1% | -17.8% | 8.6% | -7.2% | |
| -53.8% | -170.7% | -51.7% | -3.8% | -68.6% | 28.1% | -45.6% | -44.6% | -12.2% | -0.7% | -10.5% | 15.5% | -0.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.